Carlsmed, Inc.
CARL
$9.83
$0.171.76%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 6.27% | 15.99% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 6.27% | 15.99% | |||
| Cost of Revenue | 3.77% | 13.03% | |||
| Gross Profit | 7.04% | 16.93% | |||
| SG&A Expenses | 5.50% | 7.89% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.71% | 10.74% | |||
| Operating Income | 0.45% | -3.13% | |||
| Income Before Tax | -0.96% | -1.02% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -0.96% | -1.02% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.96% | -1.02% | |||
| EBIT | 0.45% | -3.13% | |||
| EBITDA | 0.47% | -2.98% | |||
| EPS Basic | -0.06% | 19.93% | |||
| Normalized Basic EPS | -0.05% | 19.94% | |||
| EPS Diluted | -0.06% | 19.93% | |||
| Normalized Diluted EPS | -0.05% | 19.94% | |||
| Average Basic Shares Outstanding | 0.90% | 26.16% | |||
| Average Diluted Shares Outstanding | 0.90% | 26.16% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||